Navigation Links
Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes
Date:5/20/2008

California infertility practice offering new out-patient procedures at no

charge for treating hydrosalpinx

SAN RAMON, Calif., May 20 /PRNewswire/ -- Compass Clinical Research and the Reproductive Science Center of the San Francisco Bay Area (RSC) are hoping to recruit between 20 to 50 women suffering from hydrosalpinx, a build-up of fluid in the fallopian tubes that can cause infertility, to receive free surgeries as a part of a study of the effectiveness of a new out-patient procedure used in conjunction with in vitro fertilization (IVF).

Dr. Donald I. Galen, Research Director at Compass Clinical Research and Reproductive Science Center's tubal reversal specialist and world pioneer in reproductive technological device development, will supervise the 20-minute procedures at RSC's San Ramon center. Compass Clinical Research and Reproductive Science Center, one of the first FDA's principal clinical investigative sites in the nation for early clinical trials with tubal closure devices, received both FDA and Institutional Review Board (IRB) approval for this new study.

The presence of a hydrosalpinx on one or both fallopian tubes has been associated with a reduction of approximately 50 percent in clinical pregnancy rates following IVF. Most reproductive specialists recommend surgical removal or closure (occlusion) of the impaired tube(s) before proceeding with IVF. The new ESSURE micro-insert off-label method for occluding tubes with hydrosalpinx is thought to increase chances of successful IVF, and it is a less invasive procedure with lower risks and costs than traditional surgery.

Fluid blockage in a fallopian tube, usually at the end closest to the ovary, makes it difficult for a woman to become pregnant. Traditional treatment with laparoscopic surgery involves the removal of part of the fallopian tube that generates the fluid. However, these surgeries are not always successful in achieving complete removal of problematic tissue and may cause new scar tissue and decrease healthy blood flow to the ovary that might affect pregnancy rates adhesions that interfere with successful embryo implantation. Laparoscopic surgeries also require general anesthesia, which poses higher risks of complications, involve up to a week of recovery, and cost an average of $6,500.

Compass Clinical Research's study will use a new procedure that does not involve any surgical incisions. The doctor inserts spring-like coils, called Essure micro-inserts, which are made from polyester fibers and metals like those used in heart valve replacements. They are inserted through the body's natural pathways (i.e., vagina, cervix, and uterus) and into the fallopian tubes. The inserts block the fallopian tubes, potentially preventing harmful fluids of the hydrosalpinx from flowing into the uterus and contacting the embryo. The procedure is performed under local anesthesia, so patients have a fast recovery 92 percent of women studied so far missed one day or less of work.

Three months following the procedure a hysterosalpingogram (HSG) will be performed to confirm sealing of the tubes. This X-ray test examines the interior of the uterus, the fallopian tubes, and surrounding areas. It injects a special contrasting dye through a thin flexible tube, or catheter that is inserted through the vagina and the cervix into the uterus. Because the uterus and the fallopian tubes are connected, the contrast material then flows into the fallopian tubes. As the dye circulates, X-ray pictures are taken to determine that the has been closed or occluded. At this time, the woman may proceed with IVF (separate from the no-fee Essure micro-insert procedure.)

Participation in the study may last eighteen months. As is the case for all procedures, there are possible risks associated with Essure micro-inserts, such as the possibility that the device(s) cannot be successfully placed, a risk of uterine perforation during placement, the possibility that tubal occlusion will not be successful, and the rare possibility of infection, bleeding or local anesthesia reaction. Based on Dr Galen's eight years of experience and its published clinical studies to date, these complications are very uncommon.

For more information regarding the study, please visit http://www.rscbayarea.com or call 925.973.5012.

About Reproductive Science Center

Established in 1983, the Reproductive Science Center of the San Francisco Bay Area was one of the earliest IVF facilities in the United States, begun just two years after the nation's first successful IVF treatment. RSC was among the first in the United States to report a successful pregnancy from an egg donated from one woman to another for gestation and delivery, and was also responsible for the nation's second successful transfer of a previously frozen embryo into a mother's uterus. Today, RSC boasts a staff of six infertility physicians with a collective 85 years' experience with offices in San Ramon, Orinda, San Jose, Fremont, Modesto and Brentwood. The Reproductive Science Center is a member of IntegraMed. For more information, visit http://www.rscbayarea.com.

About IntegraMed America, Inc.

IntegraMed America, Inc. is the leading operator of fertility centers in the United States. The IntegraMed Fertility network consists of 31 contracted centers in 101 locations across the United States, including 171 physicians and Ph.D. scientists. One of every five IVF procedures in the U.S. is performed in an IntegraMed fertility practice. IntegraMed also offers consumer treatment-financing programs and operates http://www.integramed.com, a leading fertility portal.


'/>"/>
SOURCE Compass Clinical Research; Reproductive Science Center ofthe San
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Best Practice Database Adds Research on Merger Integration and Competitive Intelligence
2. Perrigo Company to Present at the Citi Investment Research Global Health Care Conference
3. A research on craving for tobacco establishes the bases for addiction control
4. Performance Metrics -- Market Research Structure and Functions
5. With age comes a sense of peace and calm, population research center study shows
6. Researchers close in on new melanoma gene
7. Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report
8. Align Technology Names Dana C. Cambra as VP, Research & Development
9. Researchers develop first transgenic monkey model of Huntingtons disease
10. Researchers expand natural killer cells in cord blood to fight leukemia
11. Research talent wins national Innovation in Nursing award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , ... April 29, 2016 , ... ... healthcare awareness and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy ... May 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, author of ...
(Date:4/29/2016)... ... , ... Coast Dental Fort Stewart is celebrating its grand opening with an ... Furniture Mall at 112 Vilseck Road in Fort Stewart. There will be refreshments, giveaways, ... have the opportunity to meet general dentists Thomas Richards, DDS, and Josh Faulk, DMD, ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... won the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan ... the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ ...
(Date:4/29/2016)... ... April 29, 2016 , ... The ... (CCA), is pleased to announce the launch of the GFCP Scoop ... and more. The purpose of the GFCP Scoop site is to ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
(Date:4/28/2016)... N.J. , April 28, 2016   Acsis ... today announced that leading IT market research and advisory ... " in the IDC MarketScape: Worldwide Pharmaceutical Track and ... 2016).  The report provides an assessment of the capabilities ... track and trace software market. Logo - ...
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
Breaking Medicine Technology: